Director Shareholding

GlaxoSmithKline PLC 28 December 2000 Directors' Interests I give below details of changes in directors' interests in the Ordinary Shares of GlaxoSmithKline plc. 28th Abacus (GW) Trustees Limited, as trustee of The Glaxo Wellcome December Employee Trust ('the Trust'), transferred 146,564 Ordinary Shares in 2000 the Company to participants of the Glaxo Wellcome Annual Incentive Plan and the Glaxo Wellcome Long Term Incentive Plan and sold 96,628 Ordinary Shares in the Company as a result of vesting of shares under the Glaxo Wellcome Annual Incentive Plan and the Glaxo Wellcome Long Term Incentive Plan on the 27th December 2000. The Company was advised of this transaction on 28th December 2000. The Trust is a discretionary trust of which all employees or former employees of Glaxo Wellcome plc and its subsidiaries are potential beneficiaries. Two of the Company's directors, Sir Richard Sykes and John Coombe, as directors of Glaxo Wellcome plc, are therefore, interested in the shares held in the Trust from time to time in the same way as other employees or former employees of Glaxo Wellcome plc and it's subsidiaries. S M Bicknell Company Secretary 28th December 2000

Companies

GSK (GSK)
UK 100